NEWBRY
Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq
Newbury Pharmaceuticals AB has, through its subsidiary Newbury Pharmaceuticals S.A, signed an exclusivity agreement with an established Chinese pharmaceutical manufacturer granting Newbury exclusive rights to register, market and sell a portfolio of 40 products in Iraq over a ten-year term. The agreement follows several years of collaboration between the two companies. All products will be registered and sold under Newbury’s label or own brand names.